XML 89 R26.htm IDEA: XBRL DOCUMENT
v2.4.0.8

CONCENTRATIONS | 12 Months Ended
--- | ---
Dec. 31, 2013
Risks and Uncertainties [Abstract] |
Concentration Risk Disclosure [Text Block] |
18. | CONCENTRATIONS
Major Customers For the years ended December 31, 2013, 2012 and 2011, approximately 26%, 13% and 13% of the Company’s revenues were received from two major customers. No customer represented more than 10% of amounts receivable at December 31, 2013 and 2012, respectively. At December 31, 2011, receivables from two customers were approximately 12% and 10%, respectively. Major Suppliers At December 31, 2013, 2012 and 2011, payables due to three suppliers were approximately 43%, 25% and 15% of payables, 34%, 33% and 19% of payables, 50%, 8% and 6% of payables, respectively. Revenues For the years ended December 31, 2013, 2012 and 2011, the Company’s top three selling products accounted, in the aggregate, for approximately 67%, 68% and 27%, respectively, of its total net revenues. The following represents the revenues by product line, all derived from China:
|  | For the years ended |
|  | December 31, |
|  | 2013 |  | 2012 |  | 2011 |
|  | US$ |  | US$ |  | US$ |
Products Line |  |  |  |  |  |  |
Medical Devices |  | 14,824,028 |  | 18,547,635 |  | 19,362,673 |
Respiratory and Oxygen Homecare |  | 2,034,150 |  | 2,822,690 |  | 2,276,610 |
|  | 16,858,178 |  | 21,370,325 |  | 21,639,283 |

X
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6327-108592 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6404-108592 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13531-108611 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6351-108592 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13537-108611 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 21 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6442-108592 + Details
Name: | us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_RisksAndUncertaintiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration